Literature DB >> 8946830

Thymosin beta 15: a novel regulator of tumor cell motility upregulated in metastatic prostate cancer.

L Bao1, M Loda, P A Janmey, R Stewart, B Anand-Apte, B R Zetter.   

Abstract

The Dunning rat prostatic carcinoma is a model system where cell motility closely correlates with the metastatic phenotype. We have identified a novel gene, upregulated in the highly motile and metastatic Dunning cancer cell lines, that represents a new member of the thymosin-beta family, thymosin beta 15. Transfection of antisense thymosin beta 15 constructs into rat prostatic carcinoma cells demonstrates that this molecule positively regulates cell motility, a critical component of the metastatic pathway. Thymosin beta 15 levels are elevated in human prostate cancer and correlate positively with the Gleason tumor grade. Thymosin beta 15 may represent a potential new biochemical marker for human prostate cancer progression.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8946830     DOI: 10.1038/nm1296-1322

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  28 in total

1.  In silico functional profiling of individual prostate cancer tumors: many genes, few functions.

Authors:  Ivan P Gorlov; Jinyoung Byun; Christopher J Logothetis
Journal:  Cancer Genomics Proteomics       Date:  2012 May-Jun       Impact factor: 4.069

2.  Localization of thymosin beta10 in breast cancer cells: relationship to actin cytoskeletal remodeling and cell motility.

Authors:  Aase Elisabeth Maelan; Trine Kring Rasmussen; Lars-Inge Larsson
Journal:  Histochem Cell Biol       Date:  2006-06-20       Impact factor: 4.304

3.  Prostate stem cell antigen: a cell surface marker overexpressed in prostate cancer.

Authors:  R E Reiter; Z Gu; T Watabe; G Thomas; K Szigeti; E Davis; M Wahl; S Nisitani; J Yamashiro; M M Le Beau; M Loda; O N Witte
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-17       Impact factor: 11.205

4.  Thymosin beta15 expression in tumor cell lines with varying metastatic potential.

Authors:  L Bao; M Loda; B R Zetter
Journal:  Clin Exp Metastasis       Date:  1998-04       Impact factor: 5.150

5.  A quantitative transcriptome reference map of the normal human brain.

Authors:  Maria Caracausi; Lorenza Vitale; Maria Chiara Pelleri; Allison Piovesan; Samantha Bruno; Pierluigi Strippoli
Journal:  Neurogenetics       Date:  2014-09-04       Impact factor: 2.660

6.  Suppression of prostate carcinoma cell invasion by expression of antisense L-plastin gene.

Authors:  J Zheng; N Rudra-Ganguly; W C Powell; P Roy-Burman
Journal:  Am J Pathol       Date:  1999-07       Impact factor: 4.307

7.  Differential regulation of human thymosin beta 15 isoforms by transforming growth factor beta 1.

Authors:  Jacqueline Banyard; Courtney Barrows; Bruce R Zetter
Journal:  Genes Chromosomes Cancer       Date:  2009-06       Impact factor: 5.006

8.  Accurate molecular classification of cancer using simple rules.

Authors:  Xiaosheng Wang; Osamu Gotoh
Journal:  BMC Med Genomics       Date:  2009-10-30       Impact factor: 3.063

9.  Reduction of thymosin beta4 and actin in HL60 cells during apoptosis is preceded by a decrease of their mRNAs.

Authors:  Christian S G Müller; Thomas Huff; Ewald Hannappel
Journal:  Mol Cell Biochem       Date:  2003-08       Impact factor: 3.396

10.  Gene profiling of cottontail rabbit papillomavirus-induced carcinomas identifies upregulated genes directly Involved in stroma invasion as shown by small interfering RNA-mediated gene silencing.

Authors:  Evamaria Huber; Daniela Vlasny; Sonja Jeckel; Frank Stubenrauch; Thomas Iftner
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.